John Chiminski was named President and Chief Executive Officer of Catalent Pharma Solutions in March 2009.
Headquartered in Somerset, New Jersey, Catalent Pharma Solutions is a leading provider of advanced dose form and packaging technologies, and development, manufacturing and packaging services for pharmaceutical, biotechnology and consumer health care companies in nearly 100 countries. Catalent employs 9,500 people at more than 30 facilities worldwide. In fiscal 2008, Catalent generated more than $1.8 billion in annual revenue.
Mr. Chiminski has a diversified business background that includes lean manufacturing, supply chain, research and development, customer service, and global business management with a focus on customers and growth.
He joined Catalent after more than 20 years of experience at GE Healthcare in engineering, operations and senior leadership roles. From 2007 until he left in 2009, Mr. Chiminski served as President and Chief Executive Officer of GE Medical Diagnostics, a global business with sales of $1.9 billion. From 2005 to 2007, he served as Vice President and General Manager of GE Healthcare’s Global Magnetic Resonance Business, and from 2001 to 2005, Mr. Chiminski served as Vice President and General Manager of Global Healthcare Services. Earlier in his time at GE, Mr. Chiminski held a series of cross-functional leadership positions in both manufacturing and engineering, including a GE Medical Systems assignment in France.
Mr. Chiminski holds a B.S. from Michigan State University and an M.S. from Purdue University, both in electrical engineering, as well as a Master in Management degree from the Kellogg School of Management at Northwestern University.
He is on the Board of Trustees for HealthCare Institute of New Jersey.